The complete dosing chart shows the standard escalation schedule, but your provider may customize this based on your response
A medical weight loss program built around GLP-1 physiology changes that equation entirely
Drug and alcohol addiction Some people taking GLP-1 agonists for weight loss or diabetes have reported an unexpected, but often welcome side effect: decreased cravings for drugs, alcohol, and tobacco
it reflects the chronic nature of obesity as a metabolic condition
This mechanistic diversity suggests that GLP-1RAs could be repurposed to target complex, multifactorial disorders like schizophrenia, bipolar disorder, and bulimia nervosa, where current treatment options are limited or suboptimal
Theyve long been used to help people with diabetes maintain a moderate weight